• 23445 Citations
19982023
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Novel biomarkers of endocrine resistance in breast cancer. Circulating tumor cells (CTCs) and ctDNA. Drug development with focus on endocrine therapy.

Management of breast cancer with particular focus on inflammatory breast cancer (IBC), Locally Advanced Breast Cancer (LABC) and Metastatic Breast Cancer (MBC). Expertise in new endocrine therapies for hormone-receptor positive MBC.

Training Experience

1994Internship, Cabrini Medical Center, New York, NY
1996Residency, Cabrini Medical Center, New York, NY
1998Fellowship, University of Texas/MD Anderson Cancer Center

Education/Academic qualification

MD, University La Sapienza, Rome, Italy

… → 1986

Keywords

  • Breast Cancer
  • Cancer Genetics
  • Chemotherapy
  • Molecular Diagnostics
  • Oncology

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 2 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Inflammatory Breast Neoplasms Medicine & Life Sciences
Circulating Neoplastic Cells Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Survival Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2015 2023

Neutrophils
Breast Neoplasms
Neoplasm Metastasis
zileuton
T-Lymphocytes

Research Output 1998 2019

Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?

Buono, G., Gerratana, L., Bulfoni, M., Provinciali, N., Basile, D., Giuliano, M., Corvaja, C., Arpino, G., Del Mastro, L., De Placido, S., De Laurentiis, M., Cristofanilli, M. & Puglisi, F., Feb 1 2019, In : Cancer Treatment Reviews. 73, p. 73-83 11 p.

Research output: Contribution to journalReview article

Breast Neoplasms
DNA
Neoplasms
Biopsy
Precision Medicine

Combined blockade of activating ERBB2 mutations and ER results in synthetic lethality of ERþ/HER2 mutant breast cancer

Croessmann, S., Formisano, L., Kinch, L. N., Gonzalez-Ericsson, P. I., Sudhan, D. R., Nagy, R. J., Mathew, A., Bernicker, E. H., Cristofanilli, M., He, J., Cutler, R. E., Lalani, A. S., Miller, V. A., Lanman, R. B., Grishin, N. V. & Arteaga, C. L., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 277-289 13 p.

Research output: Contribution to journalArticle

Estradiol Congeners
Estrogen Receptors
Breast Neoplasms
Mutation
MCF-7 Cells
2 Citations (Scopus)

Homophilic CD44 interactions mediate tumor cell aggregation and polyclonal metastasis in patient-derived breast cancer models

Liu, X., Taftaf, R., Kawaguchi, M., Chang, Y. F., Chen, W., Entenberg, D., Zhang, Y., Gerratana, L., Huang, S., Patel, D. B., Tsui, E., Adorno-Cruz, V., Chirieleison, S. M., Cao, Y., Harney, A. S., Patel, S., Patsialou, A., Shen, Y., Avril, S., Gilmore, H. L. & 5 othersLathia, J. D., Abbott, D. W., Cristofanilli, M., Condeelis, J. S. & Liu, H., Jan 1 2019, In : Cancer Discovery. 9, 1, p. 96-113 18 p.

Research output: Contribution to journalArticle

Cell Aggregation
Breast Neoplasms
Neoplasm Metastasis
Circulating Neoplastic Cells
Neoplasms
1 Citations (Scopus)

Anaplastic lymphoma kinase mutation (ALK F1174C) in small cell carcinoma of the prostate and molecular response to alectinib

Carneiro, B. A., Pamarthy, S., Shah, A. N., Sagar, V., Unno, K., Han, H. Y., Yang, X. J., Costa, R. B., Nagy, R. J., Lanman, R. B., Kuzel, T. M., Ross, J. S., Gay, L., Elvin, J. A., Ali, S. M., Cristofanilli, M., Chae, Y. K., Giles, F. J. & Abdulkadir, S. A., Jun 15 2018, In : Clinical Cancer Research. 24, 12, p. 2732-2739 8 p.

Research output: Contribution to journalArticle

Small Cell Carcinoma
Prostate
Mutation
Organoids
Prostatic Neoplasms

Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer

Brisard, D., Eckerdt, F. D., Marsh, L. A., Blyth, G. T., Jain, S., Cristofanilli, M., Horiuchi, D. & Platanias, L. C., Dec 1 2018, In : Oncotarget. 9, 99, p. 37305-37318 14 p.

Research output: Contribution to journalArticle

Cyclin-Dependent Kinase 9
Triple Negative Breast Neoplasms
Neoplastic Stem Cells
Antineoplastic Agents
Recurrence